1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Lisa Barrett: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor), Remdesivir (antiviral) - COVID-19 | Phase 2 | Unknown | Lisa Barrett | 363 | 2020-04-17 | 2023-09-18 |
COVID-19 (1) · Coronavirus Infections (1)
Antiviral Agents (1) · Janus Kinase Inhibitors (1) · baricitinib (1) · remdesivir (1) · tocilizumab (1)
Canada (1)